Hillstream BioPharma (HILS) Insider Trading & Ownership $1.36 +0.16 (+13.34%) As of 04/28/2025 Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock Hillstream BioPharma (NASDAQ:HILS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage30.24%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$2,790.94Number OfInsiders Selling(Last 3 Years)0 Get HILS Insider Trade Alerts Want to know when executives and insiders are buying or selling Hillstream BioPharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address HILS Insider Buying and Selling by Quarter Hillstream BioPharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/17/2022Randy MilbyCEOBuy500$0.78$390.00 6/6/2022Randy MilbyCEOBuy1,000$0.69$690.00 6/1/2022Randy MilbyCEOBuy1$0.94$0.94 5/25/2022Randy MilbyCEOBuy1,000$0.79$790.00 5/20/2022Randy MilbyCEOBuy1,000$0.92$920.00 (Data available from 1/1/2013 forward) HILS Insider Trading Activity - Frequently Asked Questions Who is on Hillstream BioPharma's Insider Roster? The list of insiders at Hillstream BioPharma includes Randy Milby. Learn more on insiders at HILS. What percentage of Hillstream BioPharma stock is owned by insiders? 30.24% of Hillstream BioPharma stock is owned by insiders. Learn more on HILS's insider holdings. Hillstream BioPharma Key ExecutivesMr. Randy D. Milby MBA (Age 69)Pres, Chairman & CEO Compensation: $471.94kMr. Sireesh Appajosyula Pharm.D. (Age 47)COO & Director Compensation: $64.96kMr. Thomas P. Hess CPA (Age 59)MBA, Chief Financial Officer More Insider Trading Tools from MarketBeat Related Companies Veru Insider Ownership ESSA Pharma Insider Ownership Sagimet Biosciences Insider Ownership Cassava Sciences Insider Ownership Assembly Biosciences Insider Ownership Unicycive Therapeutics Insider Ownership MediciNova Insider Ownership Biomea Fusion Insider Ownership Exicure Insider Ownership Cumberland Pharmaceuticals Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 5 Mid-Cap Stocks Insiders Are Buying This YearInsider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or Hold This page (NASDAQ:HILS) was last updated on 4/29/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hillstream BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hillstream BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.